After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
The paediatric trials for Covaxin started in AIIMS Patna on Tuesday after Bharat Biotech's COVID-19 vaccine received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11."AIIMS Patna has started trials in the age of 12-18 years, we have started clinical trials of Covaxin after registration for this age only," said Dr Prabhat Kumar Singh, Director, AIIMS, Patna.
"After these trials, the age group will be 6-12 years and then 2-6 years but now we have started trails in the age group of 12-18 years," he added.
VK Paul, Member (Health), Niti Aayog had earlier said, "Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years."